Drug-maker Actavis Inc. said Monday that it reached an agreement with the FDA to not distribute any products from its Totowa facilities in Morristown, N.J., until it is in compliance with the agency's current good manufacturing practice.
Required improvements include upgrading equipment, and improving labs and facilities.
Actavis has faced lawsuits over its recalled heart drug Digitek, including one involving a patient's death, alleging that the drug was dangerous and defective.
Digitek was made at one of the company's Totowa facilities.
The company would not say whether the FDA agreement affected the lawsuits.